Thargor wrote: » No, those are AMAL shares, or just a placeholder for when TAW and AMAL merge then they will both be combined into one AMAL holding. Cowan shares dont exist yet and you wont be getting them anyway if you're not resident in Australia, the company will hold them in trust then sell them and give you the cash when they list.
MikeSoys wrote: » hi im looking at a share thats undergoing major changes lately...whats your share view on standard life Aberdeen -SLA? is it looking like a BUY? ...or those who are holders...a SELL...???
sasol wrote: » I am using 100 TAW shares to keep this simple. My understanding is that for every 100 TAW shares that you own A) Your TAW shares will be replaced by 110 AMAL Shares (100 TAW X 1.1) You will receive 9 COWAN Shares (100 / 11.1) Since yesterday I have extra non-transactable shares appear in my De Giro account - the amount of those shares correspond exactly to B above i.e. COWAN allocation, not AMAL.
Thargor wrote: » Oh sh1t you're right, my Degiro is the same, apologies. You will be getting 11 for AMAL for every 10 TAW shares but these new shares in my account do correspond to the Cowan ratio alright, very interesting, I wonder if all the people complaining made them change their minds?
Gangu wrote: » Any views on Applied Graphene Materials AGM? Trying to decide whether to cut my losses or weather the storm.
Gruffalo22 wrote: » After a quick review of their financials I think I would be inclined to sell. They are loss making for the last 4 years and can't even manage a gross profit. After SG&A losses are significant and not improving. I would expect the company in this situation to be selling well below book value (eg 0.3) but PB is 1.4 Loss making over a number of years No dividend High PB Negligible revenue vs costs Unless you are aware of some reason why business should improve dramatically over the next few years then I would be inclined to sell even at a loss
Pussyhands wrote: » I'm a noob but some of the tech prices are insane. Netflix doubled in value in a year. You'd really think these companies can't sustain this growth.
dumb_parade wrote: » Interesting timing. Netflix opened down nearly 10% today.
AlmightyCushion wrote: » Not that interesting. Their share price dropped yesterday too.
Kuva wrote: » At beginning of last year Netflix were gonna open in another heap of countries, loads of new shows coming, were a sure thing. No where else to open now, most of their shows are sh1te, especially marvel ones, all of their movies are sh1te, will smith one did ok, spending a fortune on a few big TV show producer names, all they can hope for is good sign ups now but who is gonna pay for, Amazon, Netflix, hbo, Disney is coming, who else is coming, they can all feck off with their only 9.99 a month. No more sure thing.
Joselyn Quaint Viewpoint wrote: » Viking Therapeutics announce , eh, an announcement of their results. Due in October, but signs suggest outcome is positive. Will the price respond I wonder? I can't post a URL but available at the link below www[dot]prnewswire[dot]com/news-releases/viking-therapeutics-announces-vk5211-phase-2-study-results-selected-for-plenary-oral-presentation-at-asbmr-2018-annual-meeting-300681783.html
Trasna1 wrote: » It fell on the back of that announcement. Presumably because there was no mention of the NASH drug trials.
Trasna1 wrote: » Joselyn Quaint Viewpoint wrote: » Viking Therapeutics announce , eh, an announcement of their results. Due in October, but signs suggest outcome is positive. Will the price respond I wonder? I can't post a URL but available at the link below www[dot]prnewswire[dot]com/news-releases/viking-therapeutics-announces-vk5211-phase-2-study-results-selected-for-plenary-oral-presentation-at-asbmr-2018-annual-meeting-300681783.html It fell on the back of that announcement. Presumably because there was no mention of the NASH drug trials.
Pussyhands wrote: » So as a noob dipping my toe in the market....any suggestions for buys?